Chargement en cours...
MiR-93 Promotes Tumorigenesis and Metastasis of Non-Small Cell Lung Cancer Cells by Activating the PI3K/Akt Pathway via Inhibition of LKB1/PTEN/CDKN1A
Background: Non-small cell lung cancer (NSCLC) accounts for approximately 85% of clinical lung cancer cases. MicroRNA-93 (miR-93) is an oncomiR in many types of human cancer, exerting pivotal effects in the development and progression of malignancies, including NSCLC. However, the mechanism underlyi...
Enregistré dans:
| Publié dans: | J Cancer |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Ivyspring International Publisher
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5381176/ https://ncbi.nlm.nih.gov/pubmed/28382150 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.17958 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|